ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
SPDR S&P Biotech ETF
156.20
-0.6200
-0.40%
盤後:
156.43
0.2300
+0.15%
19:59 EDT
成交量:
841.39萬
成交額:
13.25億
市值:
105.24億
市盈率:
8.57
高:
159.66
開:
158.27
低:
156.13
收:
156.82
52周最高:
169.89
52周最低:
92.64
股本:
6,737.50萬
流通股本:
6,737.50萬
量比:
1.28
換手率:
12.49%
股息:
0.56
股息率:
0.36%
每股收益(TTM):
18.23
淨資產收益率:
--
總資產收益率:
--
市淨率:
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞
公告
醫療健康板塊市場快訊綜述
投资观察
·
08/18
港股收評:恒指漲0.07% 科指跌0.9% 芯片股走弱 生物醫藥板塊活躍
新浪港股
·
08/18
北汽副總史志山年薪75.41萬元 連續兩年低於同期上任的副總胡漢軍
运营商财经网
·
08/18
傳童牧知擬加盟瑞銀 出任集團亞洲醫療保健投行業務主席
智通财经
·
08/18
亞太藥業等成立生物科技公司
智通财经
·
08/18
醫療保健板塊動態:市場快訊匯總
投资观察
·
08/18
醫療板塊動態:市場快訊匯總
投资观察
·
08/18
瑞銀據悉延攬高盛前老將 將負責亞洲醫療保健投行業務
智通财经
·
08/17
全球資產配置進入「去擁擠化」時刻!美銀從AI算力轉向價值、生物科技與大宗商品
智通财经
·
08/17
醫藥基金淨值大幅攀升 機構配置尚處歷史低位
智通财经
·
08/17
槍殺美國聯合健康保險CEO的曼吉奧內就聯邦指控認罪
澎湃新闻
·
08/15
路易吉,正式認罪!他此前當街槍殺美國聯合健康保險CEO,或面臨終身監禁
每日经济新闻
·
08/15
路易吉,正式認罪!他此前當街槍殺美國聯合健康保險CEO,或面臨終身監禁
每日经济新闻
·
08/15
路易吉・曼喬內在法庭上承認,他槍擊了聯合健康保險原首席執行官布萊恩・湯普森。
智通财经
·
08/14
惠譽: 隨着醫療保險和社會保障支出到 2032 年將接近增加 1 個百分點的國內生產總值,財政壓力將會加劇。
智通财经
·
08/14
「人才版圖」引領 繪就生物醫藥千億「產業藍圖」
经济参考报
·
08/14
醫療保健板塊快訊:市場動態綜述
投资观察
·
08/14
醫療保健板塊綜述:市場快訊
投资观察
·
08/13
上海:完善上海市重點產業地圖,聚焦集成電路、生物醫藥、人工智能三大先導產業
智通财经
·
08/13
民祥生物醫藥被出具警示函,涉未披露年報等
蓝鲸财经
·
08/12
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/XBI/news?page=8"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"XBI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","market":"US","secType":"STK","nameCN":"SPDR S&P Biotech ETF","latestPrice":156.2,"timestamp":1789156800000,"preClose":156.82,"halted":0,"volume":8413893,"hourTrading":{"tag":"盘后","latestPrice":156.43,"preClose":156.2,"latestTime":"19:59 EDT","volume":555911,"amount":86836947.7522,"timestamp":1789171191129,"change":0.23,"changeRate":0.001472,"amplitude":0.001601},"delay":0,"changeRate":-0.0039535773498278574,"floatShares":67375000,"shares":67375000,"eps":18.23,"marketStatus":"休市中","change":-0.62,"latestTime":"09-11 16:00:00 EDT","open":158.27,"high":159.6607,"low":156.13,"amount":1324607084.0494199,"amplitude":0.022514,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":18.23,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":156.82,"sharesOutstanding":63325000,"nav":156.174274,"aum":10736981366.38,"dividendRate":0.003615,"bidAskSpread":0.000302,"preHourTrading":{"tag":"盘前","latestPrice":158.23,"preClose":156.82,"latestTime":"09:29 EDT","volume":40501,"amount":6393566.4319400005,"timestamp":1789133399999,"change":1.41,"changeRate":0.008991,"amplitude":0.013009},"postHourTrading":{"tag":"盘后","latestPrice":156.43,"preClose":156.2,"latestTime":"19:59 EDT","volume":555911,"amount":86836947.7522,"timestamp":1789171191129,"change":0.23,"changeRate":0.001472,"amplitude":0.001601},"volumeRatio":1.2777409531718278,"optionData":{"bulkOrders":[{"symbol":"XBI","call":false,"expireDate":1790308800000,"strike":"157.0","timestamp":1789148514638,"price":3.65,"volume":2865,"amount":1045725,"type":"+"},{"symbol":"XBI","call":false,"expireDate":1790308800000,"strike":"150.0","timestamp":1789148514638,"price":1.15,"volume":2865,"amount":329475,"type":"-"}]},"impliedVol":0.2874,"impliedVolPercentile":0.1554},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","floatShares":67375000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.2777409531718278,"shares":67375000,"dividePrice":0.5646,"high":159.6607,"amplitude":0.022514,"preClose":156.82,"low":156.13,"week52Low":92.64,"pbRate":"--","week52High":169.89,"institutionHeld":0.8511,"latestPrice":156.2,"eps":18.23,"divideRate":0.003615,"volume":8413893,"delay":0,"ttmEps":18.23,"open":158.27,"prevYearClose":121.93,"prevWeekClose":163.81,"prevMonthClose":162.5,"prevQuarterClose":158.25,"fiveDayClose":164.38,"twentyDayClose":156.86,"sixtyDayClose":135.34},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBI\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"XBI","amount":0.138094,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-24","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-24"},{"date":"2025-12-22","symbol":"XBI","amount":0.406564,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XBI","amount":0.02665,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XBI","amount":0.007295,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"},{"date":"2025-03-24","symbol":"XBI","amount":0.00525,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBI\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.031139,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.01831,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.019702,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.110135,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-25","value":0.03704,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBI\",pageSize:20,pageCount:8,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1161501594","title":"醫療健康板塊市場快訊綜述","url":"https://stock-news.laohu8.com/highlight/detail?id=1161501594","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161501594?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 16:25","pubTimestamp":1787041508,"startTime":"0","endTime":"0","summary":"野村还将这家印度制药公司的2027和2028财年销售额预估每年上调约2.5%。分析师表示,Ipca Laboratories的印度制剂销售预计将维持低双位数的增长百分比。该券商将股票目标价从1,725.00卢比上调至2,060.00卢比,维持买入评级不变。股价目前报1,881.05卢比,下跌0.1%。1020 GMT——摩根大通分析师表示,阿斯利康终止一项肺癌药物试验令人失望,但其他药物的积极数据可能推动市场共识销售指引上调。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","BK4585","XBI","BK4588","LABU","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660857468","title":"港股收評:恒指漲0.07% 科指跌0.9% 芯片股走弱 生物醫藥板塊活躍","url":"https://stock-news.laohu8.com/highlight/detail?id=2660857468","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660857468?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 16:08","pubTimestamp":1787040480,"startTime":"0","endTime":"0","summary":"模拟交易客户端8月18日消息,港股三大指数涨跌不一。截至收盘,恒生指数涨0.07%,报25471.15,恒生科技指数跌0.9%,国企指数涨0.16%。猪肉股涨幅居前,牧原股份涨超4%。生物医药板块活跃,药明生物涨超4%。芯片股走弱,华虹宏力跌超7%。国金证券指出,AI正在推动半导体测试设备行业景气由传统周期修复转向结构成长。根据SEMI预测,全球半导体测试设备销售额预计于2026年同比增长31.0%至153亿美元,并于2028年达到208亿美元,2025-2028年复合增速约21%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-08-18/doc-inintpiw0093013.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02833","07300","02800","03115","513600","HHImain","07500","VXUS","03037","03419","BK4588","83115","MCHmain","399441","07200","82800","HSImain","BERZ","161726","MHImain","BK4581","HSI","KCAI","BK4585","XBI","XSEM","09115"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660468932","title":"北汽副總史志山年薪75.41萬元 連續兩年低於同期上任的副總胡漢軍","url":"https://stock-news.laohu8.com/highlight/detail?id=2660468932","media":"运营商财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660468932?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 16:08","pubTimestamp":1787040480,"startTime":"0","endTime":"0","summary":"运营商财经网 汽车频道王鑫垚/文近日,北汽集团公开高管2024年薪酬情况。数据显示,胡汉军在2024年拿到薪酬77.2万元,此外还有19.67万元的社会保险、企业年金、补充医疗保险及住房公积金的单位缴存部分。两方面合计达到96.87万元;史志山2024年薪酬为75.41万元,比胡汉军低了1.79万元。据了解,胡汉军和史志山都是在2023年上任北汽集团副总经理一职。当年,史志山的税前薪酬和综合隐性福利都不如胡汉军。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-08-18/doc-inintpin8658136.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XLV","XBI","BK4581","LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660683452","title":"傳童牧知擬加盟瑞銀 出任集團亞洲醫療保健投行業務主席","url":"https://stock-news.laohu8.com/highlight/detail?id=2660683452","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660683452?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 14:08","pubTimestamp":1787033333,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,据媒体引述知情人士透露,已从高盛离职的资深投行家童牧知(Samuel Thong),拟于10月加入瑞银集团、出任瑞银亚洲医疗保健投资银行业务主席一职。资料显示,童牧知博士在医疗保健投资银行领域深耕多年,是一位资深的医疗保健投行家,从业时间约30年,拥有芝加哥大学医学博士、MBA学位。2019年,他从摩根士丹利跳槽至高盛,出任高盛投资银行部亚洲(除日本)医疗保健团队主席,并兼任该团队联席主管。于今年早些时候,他从高盛离职。在加入摩根士丹利负责亚洲医疗保健投行业务之前,他曾任职于美银美林。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1481255.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["XLFI","KNAB","BK4581","BK4588","BK4585","IEFN","XLV","BK4550","BNKZ","IAI","NOBL","BK4582","BNKO","BCFN","VHT","FAS","CGVV","JHMF","XBI","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660945692","title":"亞太藥業等成立生物科技公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2660945692","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660945692?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 10:32","pubTimestamp":1787020356,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MEDX","AGNG","XBI","LNGR","BK4585","IEIH","BK4588","BK4581","SYNB","GDOC","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176123870","title":"醫療保健板塊動態:市場快訊匯總","url":"https://stock-news.laohu8.com/highlight/detail?id=1176123870","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176123870?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 04:54","pubTimestamp":1787000078,"startTime":"0","endTime":"0","summary":"涵盖医疗保健领域的最新市场快讯,于美国东部时间4:20、12:20及16:50在道琼斯通讯社独家发布。根据协议,两家公司将携手推进多达十种生物类似药的开发与商业化,商业化相关付款总额最高可达3.22亿美元。塞夫顿表示,此项协议\"彰显了山德士在生物类似药商业化合作领域的领先地位\"。该药物占阿斯利康为其设定的超过50亿美元销售目标的约20%。该公司股价下跌1.2%,报0.83新加坡元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XBI","BK4588","BK4585","LABU","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169996683","title":"醫療板塊動態:市場快訊匯總","url":"https://stock-news.laohu8.com/highlight/detail?id=1169996683","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169996683?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 00:26","pubTimestamp":1786983993,"startTime":"0","endTime":"0","summary":"医疗健康领域最新市场快讯,涵盖制药巨头动态与行业投资风向。根据协议,双方将共同推进多达十种生物类似药的开发与商业化,商业化相关付款总额最高可达3.22亿美元。消息公布后,山德士股价上涨3.15%,报75.3瑞士法郎。0620 GMT——摩根大通分析师认为,阿斯利康终止一项肺癌药物试验虽令人失望,但其他药物的积极数据可能推动市场对其销售指引预期上调。该股下跌1.2%,报0.83新加坡元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","XLV","BK4588","BK4585","BK4581","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660101918","title":"瑞銀據悉延攬高盛前老將 將負責亞洲醫療保健投行業務","url":"https://stock-news.laohu8.com/highlight/detail?id=2660101918","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660101918?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 11:24","pubTimestamp":1786937087,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0061475181.USD","LU2750360997.AUD","IE00B19Z3B42.SGD","LU2471134879.HKD","LU1791807156.HKD","LABU","VHT","LU1804176565.USD","LU2237443465.HKD","BK4550","LU1868837136.USD","NOBL","JHMF","LU0048573561.USD","LU0868494708.USD","LU0106831901.USD","BK4552","BCFN","LU1668664300.SGD","FAS","IE0002270589.USD","LU2237443622.USD","LU2237443978.SGD","IAI","LU1894683264.USD","LU0942090050.USD","GS","LU2750360641.GBP","BK4516","GSX","LU1868836757.USD","IE00B19Z3581.USD","LU2237443895.HKD","BNKZ","IEFN","IE0004086264.USD","LU0251142724.SGD","XLFI","LU2471134952.CNY","BK4582","CGVV","BK4127","KNAB","XLV","XBI","LU2237443382.USD","LU2237443549.SGD","BNKO","BK4588","LU2471134796.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660105476","title":"全球資產配置進入「去擁擠化」時刻!美銀從AI算力轉向價值、生物科技與大宗商品","url":"https://stock-news.laohu8.com/highlight/detail?id=2660105476","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660105476?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 09:15","pubTimestamp":1786929314,"startTime":"0","endTime":"0","summary":"不过,该行警告称,从长期来看,最大规模的增量收益可能最终流向消费者和全球整体经济,而不是那些为大规模建设AI算力基础设施提供支持的科技企业。因此,美国银行转而看好大宗商品和其他实物资产。","market":"us","thumbnail":"https://static.tigerbbs.com/55eb327f580527889cf30bafa92692ae","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/55eb327f580527889cf30bafa92692ae"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"92a7f5f4aa264c2793397c9dc1d602d4","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1480529.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["NOCT","KNOW","GMOM","SQQQ","03086","BK4585","DIA","PCPP","GDOC","SPDN","NJUL","NMBL",".DJI","GPIQ","MMAX","TCTL","UPRO","ITDJ","HIBL","03455","KOOL","159837","SPYM","VOO","SPY","DMAX","WDAI",".SPX","SMAX","AGNG","DXD","WISE","RNMN","QDEC","TQQY","IBBJ","07266","QMAR","NTSI","TQQQ","PSQ","QLD","SPXL","LEXI","SPYU","FPAA","YSPY","SSO","NJAN","DDX","DDM","161715","09834","QQQ","ARP","SDS","07522","09086","SPYQ","MEDX","UDOW","SPUU","SPXS","QQQX","07261","BK4588","DOG","IVV","NDX","07568","SYNB","BK4581","02834","QID","NDAA","ITDF","GAA","GDMA","SPXU","QALT","ITDI","LNGR","WLTG","IEIH","TBFG","DRAI","EEV",".IXIC","SH","AGOX","GAL","XBI","QPX","AVMA","SDOW","SPYH","TRIO","MVFG","QQQM","NAPR","EUCG","BTR","03034"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2660108069","title":"醫藥基金淨值大幅攀升 機構配置尚處歷史低位","url":"https://stock-news.laohu8.com/highlight/detail?id=2660108069","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660108069?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 06:17","pubTimestamp":1786918664,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","BK4550","LABU","XBI","VHT","BK4581","XLV","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659131127","title":"槍殺美國聯合健康保險CEO的曼吉奧內就聯邦指控認罪","url":"https://stock-news.laohu8.com/highlight/detail?id=2659131127","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659131127?lang=zh_tw&edition=fundamental","pubTime":"2026-08-15 09:50","pubTimestamp":1786758600,"startTime":"0","endTime":"0","summary":"据CCTV国际时讯消息,8月14日,被控枪杀美国联合健康保险公司首席执行官布赖恩·汤普森(BrianThompson)的路易吉·曼吉奥内在法庭上表示,他就其联邦刑事案件认罪,承认自己枪杀了汤普森。这一认罪协议将避免这起备受瞩目的案件进入联邦审判阶段。此外,认罪还可能使曼吉奥内得以寻求撤销纽约州的谋杀指控,并推迟即将到来的州审判。曼吉奥内目前面临联邦指控和州指控。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608153842363652.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608153842363652.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["XBI","BK4588","BK4581","XLV","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659552127","title":"路易吉,正式認罪!他此前當街槍殺美國聯合健康保險CEO,或面臨終身監禁","url":"https://stock-news.laohu8.com/highlight/detail?id=2659552127","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659552127?lang=zh_tw&edition=fundamental","pubTime":"2026-08-15 08:22","pubTimestamp":1786753353,"startTime":"0","endTime":"0","summary":"当地时间8月14日,路易吉·曼吉奥内就枪杀联合健康保险首席执行官布赖恩·汤普森(BrianThompson)一案正式认罪。联邦法官将路易吉·曼吉奥内的量刑日期定于12月18日。路易吉·曼吉奥内当天在法庭上表示,他就其联邦刑事案件认罪,承认自己枪杀了汤普森。这一认罪协议将避免这起备受瞩目的案件进入联邦审判阶段。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608153842343196.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608153842343196.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["XBI","BK4588","BK4581","LABU","BK4585","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659276311","title":"路易吉,正式認罪!他此前當街槍殺美國聯合健康保險CEO,或面臨終身監禁","url":"https://stock-news.laohu8.com/highlight/detail?id=2659276311","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659276311?lang=zh_tw&edition=fundamental","pubTime":"2026-08-15 08:22","pubTimestamp":1786753320,"startTime":"0","endTime":"0","summary":"路易吉·曼吉奥内当天在法庭上表示,他就其联邦刑事案件认罪,承认自己枪杀了汤普森。此外,认罪还可能使曼吉奥内得以寻求撤销纽约州的谋杀指控,并推迟即将到来的州审判。曼吉奥内目前面临联邦指控和州指控。州级指控方面,曼吉奥内此前面临二级谋杀、非法持有武器、持有虚假身份证明等多项罪名指控。如果二级谋杀罪名成立,曼吉奥内将面临25年至终身监禁的刑罚。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2026-08-15/doc-ininiyys3677355.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-08-15/doc-ininiyys3677355.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XBI","BK4588","LABU","BK4581","BK4585","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659128599","title":"路易吉・曼喬內在法庭上承認,他槍擊了聯合健康保險原首席執行官布萊恩・湯普森。","url":"https://stock-news.laohu8.com/highlight/detail?id=2659128599","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659128599?lang=zh_tw&edition=fundamental","pubTime":"2026-08-14 23:40","pubTimestamp":1786722026,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LABU","BK4581","XBI","XLV","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659167007","title":"惠譽: 隨着醫療保險和社會保障支出到 2032 年將接近增加 1 個百分點的國內生產總值,財政壓力將會加劇。","url":"https://stock-news.laohu8.com/highlight/detail?id=2659167007","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659167007?lang=zh_tw&edition=fundamental","pubTime":"2026-08-14 04:39","pubTimestamp":1786653589,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LABU","XBI","BK4585","BK4581","XLV","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659164273","title":"「人才版圖」引領 繪就生物醫藥千億「產業藍圖」","url":"https://stock-news.laohu8.com/highlight/detail?id=2659164273","media":"经济参考报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659164273?lang=zh_tw&edition=fundamental","pubTime":"2026-08-14 03:50","pubTimestamp":1786650640,"startTime":"0","endTime":"0","summary":"研发出首个幽门螺杆菌创新药的丹诺医药成功登陆香港联交所,用于治疗胃癌的1类创新药安尼妥单抗注射液正式获批上市,精神分裂症治疗创新药凯捷乐从苏州首发销往全国……今年以来,苏州工业园区生物医药板块“捷报”频传。生物医药创新成果竞相涌现的背后,离不开引领产业发展的人才支撑。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608143840851846.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608143840851846.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["XBI","BK4585","161726","399441","BK4581","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141376784","title":"醫療保健板塊快訊:市場動態綜述","url":"https://stock-news.laohu8.com/highlight/detail?id=1141376784","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141376784?lang=zh_tw&edition=fundamental","pubTime":"2026-08-14 00:24","pubTimestamp":1786638273,"startTime":"0","endTime":"0","summary":"医疗保健行业最新市场动态速览。该报道内容精选自专题市场快讯。该协会援引内部调查数据称,从去年1月到今年6月,Interpharma的成员企业,在总共22款新药中,有7款拒绝向瑞士医保机构提交报销申请。Interpharma表示,为了不危及美国市场的定价,药企往往会搁置其研发的新药,平均每三款就有一款暂停提交申请。KPJ Healthcare第二季度核心净利润预计将环比走强。该股目前股价持平,报3.07林吉特。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XBI","BK4588","XLV","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161156613","title":"醫療保健板塊綜述:市場快訊","url":"https://stock-news.laohu8.com/highlight/detail?id=1161156613","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161156613?lang=zh_tw&edition=fundamental","pubTime":"2026-08-13 16:24","pubTimestamp":1786609477,"startTime":"0","endTime":"0","summary":"以下为最新医疗保健板块市场快讯,内容涵盖亚太及北美市场动态。RHB维持对KPJ的“买入”评级,目标股价定为3.77林吉特。Apotex公司在公开市场首秀中,其美国业务部门成为明显的软肋。该丹麦制药商的CEO似乎对减肥药丸市场的前景非常乐观,但贝伦贝格认为,诺和诺德可能需要通过交易来增加更多的口服药物,以维持其领先地位。贝伦贝格将诺和诺德股票的评级从“买入”下调至“持有”,并将目标价从325丹麦克朗下调至305丹麦克朗。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4585","BK4588","BK4581","XLV","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659182162","title":"上海:完善上海市重點產業地圖,聚焦集成電路、生物醫藥、人工智能三大先導產業","url":"https://stock-news.laohu8.com/highlight/detail?id=2659182162","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659182162?lang=zh_tw&edition=fundamental","pubTime":"2026-08-13 10:14","pubTimestamp":1786587282,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AIBU","QQQX","ARTY","XBI","NEWZ","GPIQ","WPAI","FWD","AIQU","03034","03455","PBOT","QSWN","QTOC","AGIX","VUSE","QLD","MVPS","TECY","AIFD","QQA","NAPR","03086","09834","KOMP","CPNQ","TARK","MFIG","AQGX","PSQ","09086","TQQQ","07266","DQJN","QMAR","CHAT","TQQY","QQQ","NJAN","LCLG","SQQQ","QID","QDEC","QQQM","CWC","NJUL","NBDS","NOCT","OGIG","GK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658974771","title":"民祥生物醫藥被出具警示函,涉未披露年報等","url":"https://stock-news.laohu8.com/highlight/detail?id=2658974771","media":"蓝鲸财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658974771?lang=zh_tw&edition=fundamental","pubTime":"2026-08-12 19:44","pubTimestamp":1786535098,"startTime":"0","endTime":"0","summary":"蓝鲸新闻8月12日讯,近日,天津证监局发布行政监管措施决定书,剑指天津民祥生物医药股份有限公司及相关责任人。决定书显示,民祥医药存在以下情形:未按规定披露2025年年度报告,补充披露相关人事及股东会决议公告不及时,为子公司提供担保未履行审议程序及信息披露义务。以上行为违反了《非上市公众公司监督管理办法》和《非上市公众公司信息披露管理办法》的相关规定。公司董事长刘万里、副总经理兼董秘张毅对上述违规事项负有责任。针对上述违法行为,天津证监局对民祥医药、刘万里、张毅采取出具警示函的监督管理措施,记入证券期货市场诚信档案。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1786526206112430419","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["399441","XBI","BK4588","BK4585","BK4581","161726"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}]}}